SNCA and Parkinson disease: Regarding Parkinson’s disease, as mentioned above, a mutant form of an enzyme, alpha synuclein, has been identified for its capability of disturbing the integrity of the vesicles that contain dopamine, promoting their breakup, and favouring the release of dopamine into the cytoplasm.